1-20 of 2334
thalidomide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs

Clinical Trials & Observations
Charles J. Milrod, Frances Blevins, David Hughes, Adam Lerner, Shayna Sarosiek, Vaishali Sanchorawala, J. Mark Sloan
Journal: Blood
Blood (2021) 137 (21): 2987–2989.
https://doi.org/10.1182/blood.2021010853
Published: 2021
Includes: Supplemental data
Journal Articles

Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma

Fahrettin Covut, MD, Tariq Zuheir Kewan, MD, Apoorva Anandan, MD, Folashade Otegbeye, MBBChir,MPH, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2196.
https://doi.org/10.1182/blood-2019-125954
Published: 2019
Journal Articles

An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

Andrew D. Campbell, MD, Raffaella Colombatti, MD PhD, Biree Andemariam, MD, Crawford John Strunk, MD, Immacolata Tartaglione, MD, Connie M. Piccone, MD, Deepa Manwani, MD, Eugenia Vicky Asare, MBChB, BSc, Fatimah Farooq, Rebekah Urbonya, Gifty Dankwah, Silverio Perrotta, Laura Sainati, MD, Angela Rivers, MD, Sudha Rao, MD, William Zempsky, MD, Fredericka Sey, MBChB, Catherine Idara Segbefia, MBChB, Baba PD Inusa, MD, Charles Antwi-Boasiako, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2305.
https://doi.org/10.1182/blood-2019-127613
Published: 2019
Journal Articles

Unusually High Prevalence of Silent Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease

Bindu K Sathi, MD, Yoshida Yilin, PhD, Michael Raymond Weaver, BA, Lila Wahidi Nolan, MD, Barbara Gruner, MD, Cara Hirner, RN, BSN, Vinod V. Balasa, MBBS, Talissa Altes, MD, Carlos Leiva Salinas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2276.
https://doi.org/10.1182/blood-2019-122975
Published: 2019
Journal Articles

Cost Effectiveness of Novel Agents in the Treatment of Multiple Myeloma: A Systematic Review

Sarah Perry, MD MSc, Sylvia McCulloch, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4738.
https://doi.org/10.1182/blood-2019-125454
Published: 2019
Journal Articles

Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab

Thura Win Htut, MBBS, MRCP, Aung M Tun, MD, Anita Sultan, MD, Myint Aung Win, MDMBBS, Sriman Swarup, MDMBBS, Ei Moe Phyu, MD, Pwint Phyu Hlaing, MD, Myat Min Han, MD, Yin Mon Myat, MD, Fred Hardwicke, MD, Donald P. Quick, MD, Nicholas D'Cunha, MD, Lukman Tijani, MD, Kyaw Zin Thein, MDMBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4771.
https://doi.org/10.1182/blood-2019-123169
Published: 2019
Journal Articles

A Discrete Event Simulation Model to Evaluate the Impact of Treatment Sequences on Long-Term Patient Outcomes in Multiple Myeloma (MM)

Jinan Liu, PhD, Daniel Moldaver, PhD, Xinmei Zhu, PhD, Allen Zhou, BASc, Eric M Maiese, PhD, Sarah Hollmann, M.Biotech
Journal: Blood
Blood (2019) 134 (Supplement_1): 4737.
https://doi.org/10.1182/blood-2019-123804
Published: 2019
Journal Articles

Impact of Modified Thalidomide Dosing in Bortezomib/Thalidomide/Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant-Eligible: A Matching-Adjusted Indirect Comparison

Pieter Sonneveld, Maria-Victoria Mateos, MD PhD, Adrián Alegre, MD, Thierry Facon, MD, Cyrille Hulin, MD, Mahmoud Hashim, Talitha Vincken, Tobias Kampfenkel, MD, Sarah Cote, Philippe Moreau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4739.
https://doi.org/10.1182/blood-2019-122775
Published: 2019
Journal Articles

Comparative Efficacy and Safety of Bortezomib, Thalidomide, and Dexamethasone (VTd) without and with Daratumumab (D-VTd) from Cassiopeia Versus Vtd from Pethema/GEM in Patients with Newly Diagnosed Multiple Myeloma Using Propensity Score Matching (PSM)

Philippe Moreau, MD, Cyrille Hulin, MD, Sonja Zweegman, MD PhD, Yannan Hu, PhD, Bart Heeg, PhD, Mahmoud Hashim, Carla de Boer, Veronique Vanquickelberghe, Tobias Kampfenkel, MD, Annette Lam, Sarah Cote, Pieter Sonneveld
Journal: Blood
Blood (2019) 134 (Supplement_1): 4740.
https://doi.org/10.1182/blood-2019-123491
Published: 2019
Journal Articles

Silent Cerebral Infarcts in Sickle Cell Disease: A Systematic Review

Maite E. Houwing, MD, Rowena Grohssteiner, BSc, Anne P.J. de Pagter, MD PhD, Karin Fijnvandraat, MD PhD, Jaap Oosterlaan, Lotte Haverman, Marjolein Dremmen, Tonya White, Marjon H. Cnossen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4836.
https://doi.org/10.1182/blood-2019-130165
Published: 2019
Journal Articles

Experience with Low Dose Thalidomide in Transfusion Dependent Beta Thalassaemia in a Resource Limited Setting

Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Priyanka Soni, MD FNB, Shinto Francis Thekuddan, MBBS,MDDM, Reema Singh, MSc, Vishvdeep Khushoo, MBBS,MDDM, Sumeet Prakash Mirgh, MBBS,MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Jyotsna Kapoor, MSc, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 963.
https://doi.org/10.1182/blood-2019-131682
Published: 2019
Journal Articles

Cerebrovascular Disease and Cognition in Adults with Sickle Cell Disease

Princess Ikemenogo, BS, MS, Taniya Varughese, MSOT, OTR/L, Allison L'Hotta, OTD, OTR/L, Kamilya Hunter, MHS, Anna Bauer, BA, Regina Abel, PhD, Allison A. King, MD MPH, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 789.
https://doi.org/10.1182/blood-2019-127283
Published: 2019
Journal Articles

High Rates of Venous and Arterial Thrombotic Events in POEMS Patients: Results from the UK-Based POEMS Registry, Highlighting the Need for Therapeutic Guidelines

Zara Sayar, MD FRCPath, MRCP, Anna Weatherill, Stephen Keddie, Jonathan Sive, MD, Michael P Lunn, Mari Thomas, Shirley D'Sa
Journal: Blood
Blood (2019) 134 (Supplement_1): 714.
https://doi.org/10.1182/blood-2019-125639
Published: 2019
Journal Articles

Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

Prashant Kapoor, MD, Morie A. Gertz, MD, Betsy Laplant, MS, Gabriella C Malave, BA, Eric Wolfe, Eli Muchtar, MD, Mustaqeem A. Siddiqui, MDMBA, Wilson I Gonsalves, MD, Angie R. Emanuel, Taxiarchis Kourelis, MD, Rahma Warsame, MD, David Dingli, MD PhD, Francis K. Buadi, MB, CHB, Suzanne R. Hayman, MD, Nelson Leung, MD, Yi L. Hwa, APRN, CNP, DNP, Miriam A. Hobbs, APRN, CNP, DNP, Amie Fonder, PA-C, MS, Angela Dispenzieri, MD, Martha Q. Lacy, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 864.
https://doi.org/10.1182/blood-2019-131476
Published: 2019
Journal Articles

Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen Receptors

Max Jan, MD PhD, Ana Castano, MD, Amanda Walker, BA, Andrew A Guirguis, MD PhD, Jessica A Gasser, PhD, Amanda A Bouffard, Mikolaj Slabicki, PhD, Alexander Tepper, Daniel E Grinshpun, Taeyoon Kyung, PhD, Quinlan Sievers, MD PhD, Michael E Birnbaum, PhD, Marcela V Maus, MD PhD, Benjamin L. Ebert, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 866.
https://doi.org/10.1182/blood-2019-124210
Published: 2019
Journal Articles

Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)

Binod Dhakal, MBBS, Raphael Fraser, PhD, Zhubin Gahvari, MD, Aric C. Hall, MD, Natalie Scott Callander, MD, Saurabh Chhabra, MD, Omar Davila, Shaji K. Kumar, MD, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 783.
https://doi.org/10.1182/blood-2019-126646
Published: 2019
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)

Heinz Ludwig, MD, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, MD, Eberhard Gunsilius, MD, Klaus Podar, MD PhD, Alexander Egle, MD, Wolfgang Willenbacher, MD PhD, Ewald Wöll, MD, Reinhard Ruckser, MD, Boris Bozic, MD, Maria-Theresa Krauth, MD, Andreas Petzer, MD, Clemens A. Schmitt, MD, Sigrid Machherndl-Spandl, MD, Hermine Agis, MD, Bruno Paiva, PhD, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 696.
https://doi.org/10.1182/blood-2019-127954
Published: 2019
Journal Articles

A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Maintenance Treatment of Transplant-Eligible Patients Newly Diagnosed with Multiple Myeloma (MM)

Jesus G. Berdeja, MD, Tara K. Gregory, MD, Suman Kambhampati, MD, Bertrand M. Anz, III, MD, Stefano R. Tarantolo, MD, Anthony A. Meluch, MD, Jeffrey V. Matous, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 603.
https://doi.org/10.1182/blood-2019-130277
Published: 2019
Journal Articles

Sequential CD19- and Bcma-Specific Chimeric Antigen Receptor T Cell Treatment for RRMM: Report from a Single Center Study

Lingzhi Yan, Zhi Yan, Jingjing Shang, Xiaolan Shi, Song Jin, Liqing Kang, Su Qu, Jin Zhou, Huizhu Kang, Ruju Wang, Ying Yao, Jing Wang, Weiqin Yao, Guanghua Chen, Lei Yu, Depei Wu, MD PhD, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 578.
https://doi.org/10.1182/blood-2019-129740
Published: 2019